Bonn, Germany

Mario Ficker

USPTO Granted Patents = 1 

 

Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2024

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Mario Ficker

Introduction

Mario Ficker is a notable inventor based in Bonn, Germany. He has made significant contributions to the field of pharmaceuticals, particularly through his innovative work on oral thin films. His expertise and dedication to advancing medical technology have led to the development of a unique patent that showcases his ingenuity.

Latest Patents

Mario Ficker holds a patent for an oral thin film composed of polyvinyl alcohol and a polyvinyl alcohol-polyethylene glycol graft copolymer. This patent describes an oral thin film that includes at least one matrix layer, which contains a pharmaceutically active agent, polyvinyl alcohol, and the graft copolymer. The invention outlines a method for producing this film and its use as a medicament, highlighting its potential benefits in drug delivery systems.

Career Highlights

Ficker is currently associated with LTS Lohmann Therapie-Systeme AG, a company known for its innovative therapeutic solutions. His work at LTS has allowed him to focus on developing advanced pharmaceutical technologies that improve patient outcomes. With a patent portfolio that includes 1 patent, he continues to push the boundaries of what is possible in the field of medicine.

Collaborations

Throughout his career, Mario has collaborated with talented professionals, including Markus Müller and Michael Linn. These partnerships have fostered a creative environment that encourages the exchange of ideas and the development of groundbreaking solutions in the pharmaceutical industry.

Conclusion

Mario Ficker's contributions to the field of pharmaceuticals through his innovative patent and collaborative efforts exemplify the spirit of invention. His work continues to pave the way for advancements in drug delivery systems, ultimately benefiting patients worldwide.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…